Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 410 followers
Latest posts
Last updated about 5 hours ago
Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
about 5 hours ago
A survey of 36 U.S. gastroenterologists found that significant treatment gaps remain...
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
about 5 hours ago
As outside experts gathered for a second day to discuss adding certain...
Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
about 8 hours ago
The company is targeting Lilly ad campaigns that cite what Novo calls...
Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
about 8 hours ago
Three years after gaining three liver disease assets in its $952 million...
Amgen hands in data package in hopes of FDA hearing for Tavneos defense
about 9 hours ago
With all eyes on Tavneos’ seemingly precarious approval status in the U.S...
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
about 9 hours ago
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements...
GSK’s first lung cancer approval, a new IPO path and more
about 9 hours ago
This week on “The Top Line”: GSK’s lung cancer approval, an unusual...
Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO
about 10 hours ago
Generic drugmakers will face import tariffs in the U.S., President Donald Trump...
The CSO Model Is Endangered. Here’s How Contract Field Organizations Must Evolve to Survive.
1 day ago
Traditional CSOs prioritize speed and low costs over candidate fit. Discover why...
In FDA compounding adcomm, advisers urge against restrictions on 1st of 7 peptides
1 day ago
An FDA advisory committee has recommended that a peptide drug that was...
Roche defends 6B franc Vabysmo peak sales target despite another quarterly miss
1 day ago
On an investor call Thursday, Roche Pharmaceuticals CEO Teresa Graham assured analysts...
BeOne jumps aboard onshoring train with $300M to add small molecule production in US
1 day ago
As the recent reshoring zeal rolls on in the United States, BeOne...